Table 1 Comparison between overweight/obese men without diabetes (n = 38) and overweight/obese men with diabetes (n = 19) on demographics and medications
Men without Diabetes | Men with Diabetes | η2 | p | |
|---|---|---|---|---|
Demographics | ------- | ------- | ------- | ------- |
  Age (yrs) | 51.1 ± 6.8 | 54.2 ± 7.4 | .04 | .12 |
  Height (cm) | 175.9 ± 6.7 | 175.9 ± 5.8 | .00 | .99 |
  Mass (kg) | 92.4 ± 14.0 | 100.2 ± 23.0 | .04 | .12 |
  BMI (kg⋅m-2) | 29.9 ± 4.5 | 32.3 ± 6.7 | .04 | .12 |
  Fasting Glucose (mmol · L-1) | 5.4 ± 0.5 | 8.1 ± 1.9 | .54 | <.01* |
  HbA1c (%) | 5.5 ± 0.3 | 6.8 ± 0.9 | .51 | <.01* |
  HbA1c (mmol · mol-1) | 37 ± 4 | 50 ± 10 | .51 | <.01* |
  Trig (mmol · L-1) | 1.5 ± 0.9 | 1.7 ± 0.8 | .02 | .35 |
  HDL (mmol · L-1) | 1.2 ± 0.4 | 1.0 ± 0.2 | .08 | .04* |
  SBP (mmHg) | 130.0 ± 14.3 | 133.7 ± 16.4 | .01 | .38 |
  DBP (mmHg) | 86.6 ± 11.0 | 86.2 ± 13.3 | .00 | .90 |
  Known duration of T2DM (yrs) | ------- | 2.5  ±  3.6 | ------- | ------- |
Medications | ------- | ------- | ------- | ------- |
  Calcium channel blockers | 0 | 3 | ------- | ------- |
  ACE inhibitors | 5 | 4 | ------- | ------- |
  Beta-blockers | 2 | 3 | ------- | ------- |
  Cholesterol lowering medication | 2 | 11 | ------- | ------- |
  Glucose lowering medication | 0 | 12 | ------- | ------- |
  Angiotensin II receptor antagonist | 1 | 4 | ------- | ------- |
  Platelet inhibitor | 0 | 2 | ------- | ------- |
  Anti-depressants | 2 | 3 | ------- | ------- |
  Aspirin | 0 | 6 | ------- | ------- |